Update of the minimally invasive therapies for benign prostatic hyperplasia

Current Opinion in Urology

Volumn 15, Issue 1, 2005, Pages 49-53

  Naspro, Richard ^a   Salonia, Andrea ^a   Colombo, Renzo ^a   Cestari, Andrea ^a   Guazzoni, Giorgio ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Benign prostatic hyperplasia; Minimal invasive surgery for BPH

Indexed keywords

ALCOHOL;

COST EFFECTIVENESS ANALYSIS; ENUCLEATION; FOLLOW UP; HOLMIUM LASER; HUMAN; LASER COAGULATION; LASER SURGERY; LONG TERM CARE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION;

HUMANS; HYPERTHERMIA, INDUCED; LASER SURGERY; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; SCLEROTHERAPY; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 12144276669     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200501000-00012     Document Type: Review

References (30)

1. Mebust WK, Hotgrewe HL, Cockett ATK, Peters PC and writing committee. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol 1989; 141:243-247.
2. Leliefeld HH, Stoevelaar HJ, McDonnell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. BJU Int 2002; 89:208-213.
3. De la Rosette JJ, Alivizatos G, Madersbacher S, et al. European Association of Urology: EAU Guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2001; 40:256-263.
4. American Urological Association guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003, 170.
5. Montorsi F, Guazzoni G, Bergamaschi F, et al. Long-term clinical reliability of transurethral and open prostatectomy for benign prostatic obstruction: a term of comparison for nonsurgical procedures. Eur Urol 1993; 23:262-265.
6. De la Rosette JJ, Gravas S, Muschter R, et al. European Society of Uro-Technology. Present practice and development of minimally invasive techniques, imaging and training in European urology: results of a survey of the European Society of Uro-Technology (ESUT). Eur Urol 2003; 44:346-351. A report that helps in understanding the progress and current situation in everyday urological practice in Europe.
7. Poulakis V, Dahm P, Witzsch U, et al. Transurethral electrovaporization vs transurethral resection for symptomatic prostatic obstruction: a meta-analysis. BJU Int 2004; 94:89-95. Meta-analysis comparing transurethral electrovaporization and TURP.
8. Van Melick HH, van Venrooij GE, Boon TA. Long-term follow-up after transurethral resection of the prostate, contact laser prostatectomy, and electrovaporization. Urology 2003; 62:1029-1034. Interesting report on three minimaliy invasive techniques, with long-term follow up.
9. Tan AHH, Gilling PJ, Kennett H, Fletcher H, et al. Long term results of high power holmium laser vaporization (ablation) of the prostate. BJU Int 2004; 92:707-709.
10. Reich O, Bachmann A, Schneede P, et al. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004; 171:2502-2504.
11. Dincel C, Samli M, Culer C, et al. Plasma kinetic vaporization of the prostate: clinical evaluation of a new technique. J Endourol 2004; 18:293-298.
12. Barber NJ, Muir GH. High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol 2004; 14:21-215.
13. Anson K. Could the latest generation potassium titanyl phosphate lasers be the ones to make transurethral resection of the prostate an operation of historical interest only? Curr Opin Urol 2004; 14:27-29. One of the few reviews to focus on the latest generation potassium titanyl phosphate lasers.
14. Tooher R, Sutherland P, Costello A, et al. A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol 2004; 171:1773-1781. Very well conducted review of the present literature regarding holmium laser prostatectomy.
15. Westenberg A, Gilling P, Kennett K, et al. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004; 172:616-619. Important long-term data presented comparing holmium laser enucleation and TURP from the first centre to perform and describe the holmium laser technique.
16. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate vs transurethral electrocautery resection of the prostate. J Urol 2004; 172:1012-1016.
17. Laguna MP, Alivizatos G, De la Rosette JJM. Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended? J Endourol 2003; 17:595-600.
18. Trock BJ, Brotzman M, Utz WJ, et al. Long-term pooled analysis of multicenter studies of cooled thermotherapy for benign prostatic hyperplasia results at three months through four years. Urology 2004; 63:716-721. This study contains an interesting meta-analysis of studies regarding thermotherapy with variable follow-up.
19. Kobelt G, Spangberg A, Mattiasson A. The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia. BJU Int 2004; 93:543-548.
20. Gordon NS. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2004; 93:1118-1119.
21. De la Rosette JJ, Floratos DL, Severens JL, et al. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2003; 92:713-718. This was one of the first papers addressing an accurate cost analysis of TUMT.
22. Huidobro C, Bolmsjo M, Larson T, et al. Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping. J Urol 2004; 171:672-678. Well conducted study to assess correctly thermal damage induced by TUMT.
23. Dicuio M, Knutson T, Vesely S, et al. 30-MINUTES-TUMT: use of the visual analogue scale to investigate patients' pain perception, different cocktail options and tolerability during 30 minutes' treatment. Urol Int 2004; 73:130-136.
24. Muschter R. Conductive heat: hot water-induced thermotherapy for ablation of prostatic tissue. J Endourol 2003; 17:609-616.
25. Goya N, Ishikawa N, Ito F, et al. Transurethral ethanol injection therapy for prostatic hyperplasia: 3-year results. J Urol 2004; 172:1017-1020. Long-term follow up presented for ethanol injection therapy.
26. Hill B, Belville W, Bruskewitz R, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004; 171:2336-2340. Interesting long-term follow up comparing standard TURP and TUNA.
27. Boyle P, Robertson C, Vaughan ED, Fitzpatrick JM. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int 2004; 94:83-88. Meta-analysis on TUNA.
28. Braun M, Mathers M, Bondarenko B, Engelmann U. Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA). Review of the literature and six years of clinical experience. Urol Int 2004; 72:32-39.
29. Chandrasekar P, Virdi JS. Transurethral needle ablation of the prostate (TUNA): a prospective study, six years follow-up. In: AUA Annual Meeting Clinical Abstracts. Lippincott Williams & Wilkins; 2001.
30. Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. Lancet 2003; 361:60-62.